Inagene Diagnostics Inc.’s CEO featured alongside global expert advocates highlighting pharmacogenomic (gene-drug compatibility) testing as a game-changing innovation to safeguard the health of Canadians November 09, 2021 Click here to read the article on the GlobeNewswire website Share Share on Facebook Tweet Tweet on Twitter Pin it Pin on Pinterest
